|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.80 USD | 0.00% |
|
+1.59% | -2.52% |
| 08-11 | Tango Therapeutics Q2 Net Loss Widens | MT |
| 08-06 | European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading | MT |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 20,202 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 3.62% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 9,423 | 10,760 | 11,246 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | -23.74% | 14.19% | 4.52% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -14.6x | -15.2x | -19.7x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.15x | 1.24x | 1.34x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | -0.9x | 3.92x | 0.9x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 11x | 10.8x | 8.71x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 5.15x | 5.77x | 4.85x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -6.72x | -7.31x | -10.4x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -5.3x | -6.34x | -8.9x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -5.4x | -6.51x | -7.9x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -18.5% | -15.4% | -12.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -5.507 | -5.294 | -4.073 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 1,830 | 1,864 | 2,318 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,403 | -1,472 | -1,080 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,779 | -1,697 | -1,263 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,341 | -1,339 | -1,002 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -10,779 | -9,442 | -8,956 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 80.42 | 80.42 | 80.42 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 251,204 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.59x | 5.14x | -6.7x | -.--% | 23.31B | |
| 21.3x | 7.43x | 15.26x | 1.36% | 70.85B | |
| 31.57x | 8.07x | 24.56x | 0.05% | 55.41B | |
| -88.15x | 15.96x | -81.34x | -.--% | 29.43B | |
| 30.62x | 6x | 15.89x | -.--% | 24.12B | |
| 25.2x | 4.79x | 16.23x | -.--% | 18.37B | |
| 51.07x | 20.81x | 53.59x | 0.07% | 16.99B | |
| -1224.8x | 38.15x | -15185.1x | -.--% | 16.1B | |
| 16.43x | 4.85x | 11.32x | -.--% | 13.12B | |
| -24.9x | 25.17x | -28.03x | -.--% | 12.48B | |
| Average | -117.62x | 13.64x | -1,516.43x | 0.15% | 28.02B | |
| Weighted average by Cap. | -62.18x | 11.21x | -868.05x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
